
Evolet Healthcare Profile
Key Indicators
- Authorised Capital ₹ 38.50 Cr
- Paid Up Capital ₹ 36.19 Cr
- Company Age 14 Year, 19 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 20.00 Cr
- Revenue Growth 12.92%
- Profit Growth -265.86%
- Ebitda -717.28%
- Net Worth 17.00%
- Total Assets 20.96%
About Evolet Healthcare
Evolet Healthcare Private Limited (EHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 February 2011 and has a history of 14 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 38.50 Cr and a paid-up capital of Rs 36.19 Cr.
The company has closed loans amounting to ₹20.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Evolet Healthcare Private Limited India is Aman Kaur as COMPANY SECRETARY. Zafarkhon Mirzoev, Sadullo Abdulloev, and Khayrullo Avgonov serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33100DL2011PTC213448
- Company No.
213448
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Evolet Healthcare?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aman Kaur ![]() | Company Secretary | 01-Sep-2022 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Zafarkhon Mirzoev ![]() | Director | 07-Feb-2011 | Current |
Sadullo Abdulloev ![]() | Director | 07-Feb-2011 | Current |
Khayrullo Avgonov ![]() | Director | 03-Aug-2012 | Current |
Financial Performance of Evolet Healthcare.
Evolet Healthcare Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 12.92% increase. The company also saw a substantial fall in profitability, with a 265.86% decrease in profit. The company's net worth Soared by an impressive increase of 17%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Evolet Healthcare?
In 2021, Evolet Healthcare had a promoter holding of 83.51% and a public holding of 16.49%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Spey Medical Private Limited
Zafarkhon Mirzoev and Sadullo Abdulloev are mutual person
- Evolet Private Limited
Zafarkhon Mirzoev, Sadullo Abdulloev and 1 more are mutual person
- Neo Universe Pharmaceuticals Private Limited
Sadullo Abdulloev is a mutual person
- Vegapharm Life Sciences Private Limited
Sadullo Abdulloev is a mutual person
- Spey Private Limited
Sadullo Abdulloev is a mutual person
Charges (Loans)
₹0
₹20.00 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 20.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Apr 2024 | Hdfc Bank Limited | ₹20.00 Cr | Satisfied |
How Many Employees Work at Evolet Healthcare?
Evolet Healthcare has a workforce of 43 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Evolet Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evolet Healthcare's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.